Literature DB >> 3443164

Non-invasive diagnosis of pulmonary hypertension in chronic obstructive pulmonary disease. Comparison of ECG, radiological measurements, echocardiography and myocardial scintigraphy.

M Oswald-Mammosser1, T Oswald, E Nyankiye, M C Dickele, D Grange, E Weitzenblum.   

Abstract

The respective value of four non-invasive methods for the diagnosis of pulmonary arterial hypertension (PAH) was investigated in 63 COPD patients, using right heart catheterization as the reference method: 22 patients had no resting PAH (pulmonary artery mean pressure (PAP) less than or equal to 20 mmHg); 26 patients had mild PAH (PAP = 21-30 mmHg); and 15 patients had moderate to severe PAH (PAP greater than 30 mmHg). The specificity of ECG was 86% and the sensitivity 51% (only 38% in mild PAH). The specificity of radiological measurements was 63% and the sensitivity 46% (38% in mild PAH). Echocardiography (echo) had the best results with a specificity of 75% and a sensitivity of 78% (73% in mild PAH), but reliable echo measurements were available in only 52 out of 63 patients. Myocardial scintigraphy had a specificity of 68% and a sensitivity of 66% (58% in mild PAH). A stepwise regression analysis (including one echo, one ECG, one radiological and one functional variable) explained only 43% of the variance of PAP (multiple r = 0.66). These results suggest that no individual method is sufficiently reliable for predicting the presence of PAH, and particularly mild PAH, but the combination of echo + myocardial scintigraphy allows the prediction of PAH with a good probability. The precise level of PAH cannot be estimated, even when using multiple regression equations.

Entities:  

Mesh:

Year:  1987        PMID: 3443164

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  9 in total

Review 1.  Should patients have right heart catheterization prior to long-term oxygen treatment?

Authors:  E Weitzenblum; M Apprill; M Ehrhart; M Oswald
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Management of Pulmonary Hypertension in Patients with Chronic Lung Disease.

Authors:  Joan Albert Barberà; Isabel Blanco
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 3.  Right ventricular dysfunction in chronic lung disease.

Authors:  Todd M Kolb; Paul M Hassoun
Journal:  Cardiol Clin       Date:  2012-05       Impact factor: 2.213

4.  Initial risk assessment for pulmonary hypertension in patients with COPD.

Authors:  Eric J Gartman; Michael Blundin; James R Klinger; Joe Yammine; Mary B Roberts; F Dennis McCool
Journal:  Lung       Date:  2011-11-18       Impact factor: 2.584

Review 5.  [Obstructive pulmonary diseases and pulmonary hypertension].

Authors:  C Neumann; C Volk; A R Wewel; J Braun
Journal:  Internist (Berl)       Date:  2009-09       Impact factor: 0.743

Review 6.  Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.

Authors:  Joan Albert Barberà; Isabel Blanco
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

7.  Combined use of non-invasive techniques to predict pulmonary arterial pressure in chronic respiratory disease.

Authors:  J M Bishop; M Csukas
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

Review 8.  Updated Perspectives on Pulmonary Hypertension in COPD.

Authors:  Isabel Blanco; Olga Tura-Ceide; Victor Ivo Peinado; Joan Albert Barberà
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-06-09

Review 9.  Pulmonary hypertension associated with COPD.

Authors:  Jean Elwing; Ralph J Panos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.